| ID | Name | CAS | Data |
MW (g/mol) |
| 13-592-0 |
trans-2-[2'-(2"-Methyl-1"-propenyl)cyclopropyl]propan-2-ol
|
38996-80-4 |
4 | 154.25 |
| 13-737-9 |
Benzoic acid, 2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]-, 1-methylethyl ester
|
|
4 | 345.40 |
| 13-841-3 |
9H-purine, 2-amino-6-methyl-9-beta-d-ribofuranosyl-
|
|
4 | 281.27 |
| 13-844-0 |
1,5-diazabicyclo[4.4.0]dec-6-ene (DBD)
|
|
4 | 138.21 |
| 13-864-8 |
1H-Indene, 2,3-dihydro-1,1,2,3,3-pentamethyl-
|
|
4 | 188.31 |
| 14-060-9 |
1,4-Dihydro-1,2,3,4,9,9-hexachloro-1,4-methanonaphthalene-5,8-diol
|
5210-87-7 |
4 | 380.87 |
| 14-075-3 |
9H-purine-6(1h)-thione, 1-methyl-9-beta-d-ribofuranosyl-
|
|
4 | 298.32 |
| 14-195-0 |
1,2,4-Methenocyclopenta[cd]pentalene-5-carboxaldehyde, 2,2a,3,3,4,7-hexachlorodecahydro-, (1«alpha»,2«beta»,2a«beta»,4«beta»,4a«beta»,5«beta»,6a«beta»,6b«beta»,7R*)-
|
7421-93-4 |
4 | 380.91 |
| 14-615-3 |
Cyclohexanone, 2-(3-chloro-2-butenyl)-2-methyl-6,6-diphenyl-
|
|
4 | 352.90 |
| 14-894-4 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTMS
|
|
4 | 374.63 |
| 14-962-8 |
1,1,1,5,5,5-Hexafluoroacetylacetone iron(III) salt
|
17786-67-3 |
4 | 677.00 |
| 15-122-9 |
3-«alpha»,4-«xi»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 639.14 |
| 15-327-2 |
Cyclohexanecarboxylic acid, 1,3-dihydroxy-4,5-(isopropylidenedioxy)-, gamma-lactone, 1-acetate
|
|
4 | 256.25 |
| 15-544-1 |
1,4,4-(CH3)3-1,2,3,4-tetrahydropyridine
|
|
4 | 125.21 |
| 15-634-1 |
Valeric acid, 3-hydroxy-2,2,4-trimethyl, beta-lactone
|
|
4 | 142.20 |
| 15-718-8 |
5-«alpha»-Cholanoic acid, 3-«alpha»-12-«beta»-dihydroxy, methyl ester, TMS
|
|
4 | 550.96 |
| 15-730-4 |
3-Thiophenamine, tetrahydro-N-methyl-N-nitroso-, 1,1-dioxide
|
|
4 | 178.21 |
| 15-885-3 |
7-Oxo-3«alpha»-hydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | 476.76 |
| 15-907-8 |
Naphthalene, 3,4,4a,5,6,7,8,8a-octahydro-7-isopropylene-1,4a-dimethyl-
|
35387-23-6 |
4 | 204.35 |
| 15-953-7 |
Bicyclo[2.2.1]hept-2-ene, 1,2,3,4,5,7,7-heptachloro-
|
5202-36-8 |
4 | 335.27 |
| 16-119-2 |
Cyclohexanemalonic acid, 5-hydroxy-2-(1-hydroxyethyl)-4,4-dimethyl-alpha-[1-(dimethylamino)prop-2-yl]-gamma,delta-dilactone
|
|
4 | 323.43 |
| 16-341-5 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-ethenyl-
|
2097-18-9 |
4 | 201.30 |
| 16-602-5 |
3-«alpha»,6-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 550.96 |
| 16-851-9 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(1-methylbutyl)-
|
28239-47-6 |
4 | 254.33 |
| 16-907-7 |
8-Azabicyclo[3.2.1]octane-3,6-diol, diacetate (ester)
|
20399-48-8 |
4 | 241.28 |
| 16-934-7 |
5«beta»-cholanoate,3«alpha»,7«alpha»-dihydroxy, methyl ester-trimethylsilyl ether
|
|
4 | 550.96 |
| 17-583-6 |
«alpha»-D-Glucopyranoside, 1,3,4,6-tetra-O-methyl-«beta»-D-fructofuranosyl 2,3,4-tri-O-methyl-6-O-(2,3,4,6-tetra-O-methyl-«alpha»-D-galactopyranosyl)-
|
34141-00-9 |
4 | 658.73 |
| 17-776-2 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (20-O)-TBDMSi
|
|
4 | 434.77 |
| 17-810-3 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 376.65 |
| 18-160-4 |
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt, hydrate (1:1:1:4)
|
6381-59-5 |
4 | 282.22 |
| 18-266-7 |
2,2,2-Trichloro-n,n'-bis(p-bromophenyl) ethylidene diamine
|
|
4 | 473.42 |
| 18-320-6 |
Nickel,bis(1,1,1-trifluoro-2,4-pentanedionato-O,O')-
|
14324-83-5 |
4 | 364.85 |
| 18-493-5 |
2-Hydroxy-3-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 396.67 |
| 18-878-8 |
2,4-Dimethoxy-6-(2-fluoro-2,2-dinitroethoxy)-1,3,5-triazine
|
|
4 | 293.17 |
| 18-902-0 |
3,6-Dioxa-2,7-disilaoctane, 2,2,4,7,7-pentamethyl-
|
17887-27-3 |
4 | 220.46 |
| 19-082-0 |
1H-Pyrazole, 3,5-bis(1,1-dimethylethyl)-4-methyl-
|
18712-47-5 |
4 | 194.32 |
| 19-619-4 |
Thiosulfuric acid (H2S2O3), S-[2-[(tetrahydro-1,1-dioxido-3-thienyl)amino]ethyl] ester
|
37018-35-2 |
4 | 275.37 |
| 19-679-8 |
2,3-Diazabicyclo[2.2.2]octa-2,5-diene N-oxide
|
37436-17-2 |
4 | 124.14 |
| 20-256-5 |
1H-Indene, 1,1,2,3,4,5,6,7-octafluoro-
|
|
4 | 260.08 |
| 20-545-4 |
Methanone, bis(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)-
|
|
4 | 272.39 |
| 20-651-6 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»)-
|
7337-91-9 |
4 | 362.62 |
| 21-208-7 |
Rhodium, bis(.eta.2-ethene)(2,4-pentanedionato-O,O')-
|
|
4 | 258.12 |
| 21-343-7 |
2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-methoxy-
|
4025-80-3 |
4 | 205.28 |
| 21-375-2 |
2-Naphthalenol, 1-[[2-methyl-4-[(2-methylphenyl)azo]phenyl]azo]-
|
85-83-6 |
4 | 380.44 |
| 22-119-5 |
3-Cyano-4-methoxymethyl-5-nitro-6-methyl-(2-pyridone)
|
|
4 | 223.19 |
| 22-220-2 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, ethyl ester
|
|
4 | 249.69 |
| 22-237-4 |
Cholesta-8,24-dien-3-ol, acetate, (3.beta.,5.alpha.)-
|
|
4 | 426.68 |
| 22-284-2 |
3«alpha»,7«alpha»-Dihydroxy-5«beta»-cholestanoic acid, MeTMS
|
|
4 | 637.17 |
| 22-425-5 |
6S-2,3,8,8-Tetramethyltricyclo[5.2.2.0(1,6)]undec-2-ene
|
137235-48-4 |
4 | 204.35 |
| 22-480-4 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-ethyl-
|
2097-16-7 |
4 | 203.31 |
| 22-537-1 |
3«alpha»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 550.96 |
| 22-640-6 |
2-Pentene-1-thione,4,4,5,5-tetrafluoro-3-hydroxy-1-phenyl-
|
|
4 | 264.24 |
| 22-683-9 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2-octyl ester
|
|
4 | 377.52 |
| 22-711-7 |
Androst-5-en-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»)-
|
3747-91-9 |
4 | 360.61 |
| 22-837-8 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«beta»,5«alpha»)-
|
57711-44-1 |
4 | 404.70 |
| 22-864-8 |
4-ethyl-2,5-dimethoxy-«beta»-phenethylamine-M, (hydroxyl-N-acetyl)-isomer 1, acetylated
|
|
4 | 309.36 |
| 23-137-4 |
Menthyl 5-methyl-bicyclo[2.2.1]hept-2-en-5-carboxylate
|
|
4 | 290.45 |
| 23-353-4 |
6-Chloro-N,N'-(cyclopentyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | 281.79 |
| 23-363-3 |
21-Hydroxypregn-4-en-3,20-dione, 20,21-methylboronate
|
|
4 | 354.30 |
| 23-404-7 |
3aH-Cyclopentacycloocten-3a-ol, 1,2,3,4,7,8,9,9a-octahydro-1,5,8,8-tetramethyl-, [1R-(1«alpha»,3a«beta»,9a«alpha»)]-
|
58542-75-9 |
4 | 222.37 |
| 23-441-6 |
5-ethyl-7-pentyl-1,2,3,4,6-pentathiepane
|
|
4 | 286.58 |
| 23-495-7 |
Cyclohexyl 2-deoxy-3,4,6-tri-O-methyl-2-(N-methylacetamido)-«alpha»-D-mannopyranoside
|
|
4 | 359.46 |
| 23-577-6 |
5«alpha»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-92-4 |
4 | 450.80 |
| 23-731-4 |
5-Pregnen-3«beta»-ol-20-one, tert-butyldimethylsilyl ether
|
|
4 | 430.74 |
| 23-873-7 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
4867-14-5 |
4 | 362.62 |
| 23-881-8 |
L-Tyrosine, N,O-bis(2,6-difluorobenzoyl)-, methyl ester
|
|
4 | 475.39 |
| 24-187-8 |
cis-5,8,11,14,17-Eicosapentaenoic acid, picolinyl ester
|
|
4 | 393.56 |
| 24-259-8 |
D-Alanine, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, propyl ester
|
|
4 | 319.28 |
| 24-360-5 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-6-one, dodecahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»,14a«alpha»)]-
|
1218-51-5 |
4 | 248.36 |
| 24-406-4 |
1-Alpha-2-methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline
|
10421-76-8 |
4 | 413.42 |
| 24-863-7 |
Phosphorothioic acid, O,O-diethyl O-[2-(ethylsulfinyl)ethyl] ester
|
|
4 | 274.34 |
| 25-279-5 |
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-
|
|
4 | 136.11 |
| 25-709-7 |
Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione
|
|
4 | 163.14 |
| 25-777-2 |
N-tert-Butyl-6-chlor-[1,3,5]triazin-2,4-diamine
|
|
4 | 201.66 |
| 26-296-5 |
1H-Indole, 2,3-dihydro-1,3,3-trimethyl-2-methylene-
|
118-12-7 |
4 | 173.25 |
| 26-559-3 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)undecyloxy-
|
|
4 | 382.70 |
| 26-843-7 |
20«beta»,21-Dihydroxypregn-4-en-3-one, 20,21-bis-TMS
|
|
4 | 476.84 |
| 27-514-1 |
2-Cyclopenten-1-one, 4-hydroxy-3-methyl-2-(2-propenyl)-
|
551-45-1 |
4 | 152.19 |
| 27-640-1 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)isohexyloxy-
|
|
4 | 312.56 |
| 27-739-2 |
1-«beta»,3-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 639.14 |
| 28-313-3 |
17-«alpha»-Methyl-5-«beta»-androst-1-ene-3-«alpha»,17-«beta»-diol
|
|
4 | 304.47 |
| 28-354-8 |
3«beta»-Hydroxy-7«alpha»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 492.81 |
| 28-714-8 |
4-Heptene-3-thione,6,6,7,7-tetrafluoro-5-hydroxy-
|
88566-62-5 |
4 | 216.20 |
| 28-741-8 |
Androsta-1,4-diene-16beta-propionic acid, 17beta-hydroxy-3-oxo-, delta-lactone
|
|
4 | 340.46 |
| 28-747-2 |
Sebacic acid, di(2,7-dimethylocta-7-en-5-yn-4-yl) ester
|
|
4 | 470.69 |
| 29-039-7 |
3«beta»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 550.96 |
| 29-107-1 |
4-Isopropyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane
|
51486-55-6 |
4 | 176.15 |
| 29-118-9 |
3-[Bis(4-methoxyphenyl)amino]-2-benzofuran-1(3h)-one
|
95166-04-4 |
4 | 361.39 |
| 29-126-0 |
5,6-Dihydro-5-methyl-4H-1,3,5-dithiazine
|
|
4 | 135.26 |
| 29-665-2 |
2,6-Naphthalenedicarboxylic acid, 3-[4-[decahydro-5-hydroxy-1-(methoxycarbonyl)-1-methyl-2-naphthalenyl]butyl]-1-methoxy-7-methyl-, dimethyl ester
|
56704-52-0 |
4 | 568.70 |
| 30-482-3 |
3-«beta»-Hydroxy-D-homo-5-androsten-17-one, TMS
|
|
4 | 403.67 |
| 30-686-7 |
Cyclopropanecarboxylic acid, 2,7-dimethyloct-7-en-5-yn-4-yl ester
|
|
4 | 220.31 |
| 31-293-2 |
3«alpha»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 639.14 |
| 31-743-2 |
2,6-Pyridinedicarboxylic acid, 2-chloro-6-fluorophenyl ethyl ester
|
|
4 | 323.70 |
| 31-790-0 |
1H-Pyrrole, 3-ethyl-5-[(4-ethyl-3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]-2,4-dimethyl-
|
2407-83-2 |
4 | 256.39 |
| 31-901-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate
|
|
4 | 360.34 |
| 31-938-6 |
Phosphorothioic acid, O-(1,6-dihydro-6-oxo-1-phenyl-3-pyridazinyl) O,O-diethyl ester
|
119-12-0 |
4 | 340.33 |
| 32-032-0 |
(+)-(1R,6R,10S)-Amorpha-4,7(11)-dien-2-one
|
|
4 | 218.34 |
| 32-154-5 |
11B-Hydroxyandrosterone (5A-Androstan-3A,11B-diol-17-one), TMS
|
|
4 | 450.81 |
| 32-281-4 |
6-Methyl-3,5-heptadien-2-one, PFBO # 1
|
|
4 | 319.27 |
|
« Previous Results
Next Results »
|